Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy.
Boon
T
T
Ludwig Institute for Cancer Research, Brussels Branch, Belgium.
D000951:Antigens, Neoplasm / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D008545:Melanoma / Q000276:immunology; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins; D009369:Neoplasms / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000951:Antigens, Neoplasm; C072011:MAGEA1 protein, human; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins